UK's CAT outlines ambitious growth plans

Cambridge Antibody Technology is unveiling some ambitious growth plans. CAT, which was recently acquired by AstraZeneca, has leased a 92,000-square-foot lab and office complex and plans to start hiring new staffers in the UK. The new building will house up to 300 employees. AstraZeneca is looking to CAT's work in antibodies to provide some of the exciting new drug discoveries its own lab has failed to produce.

- here's the report on CAT's plans from Siliconfen Business